Rapport Therapeutics (RAPP) IPO deck
Rapport Therapeutics is a clinical-stage biopharmaceutical company developing precision small molecule therapies to transform CNS disorder treatments.
Rapport Therapeutics is a clinical-stage biopharmaceutical company developing precision small molecule therapies to transform CNS disorder treatments.
%20IPO%20deck){kind=link}